Creatine
In clinical developmentAlso known as ((amino(Imino)methyl)(methyl)amino)acetic acid, (N-methylcarbamimidamido)acetic acid, (alpha-Methylguanido)acetic acid, Kreatin+7 more
((amino(Imino)methyl)(methyl)amino)acetic acid, (N-methylcarbamimidamido)acetic acid, (alpha-Methylguanido)acetic acid, Kreatin, Methylglycocyamine, N-(aminoiminomethyl)-N-methylglycine, N-amidinosarcosine, N-carbamimidoyl-N-methylglycine, N-methyl-N-guanylglycine, alpha-Methylguanidino acetic acid, Creatin.
Recent clinical, regulatory, research and industry developments relating to this drug.
Creatine doesn't just build muscle. It may also help fight cancer
Scientists say creatine may help fight depression
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes3
Journals, researchers & institutions
- Amino acids1
- Circulation1
- Frontiers in immunology1
- Cook EF1
- Donaldson MC1
- Goldman L1
- Ho KK1
- Lee TH1
- Ludwig LE1
- Mangione CM1
- Marcantonio ER1
- Biofluid Biomarker Center1
- Brigham and Women's Hospital and Harvard Medical School1
- Jichi Medical University1
- School of Basic Medical Sciences1
- Texas A&M University1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Creatine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials